183
Views
4
CrossRef citations to date
0
Altmetric
Articles

Synthesis and characterization of 4′-C-guanidinomethyl-2′-O-methyl-modified RNA oligomers

, , &
Pages 280-291 | Received 31 Jul 2019, Accepted 06 Sep 2019, Published online: 18 Sep 2019

References

  • Shen, X.; Corey, D. R. Chemistry, Mechanism and Clinical Status of Antisense Oligonucleotides and Duplex RNAs. Nucleic Acids Res. 2018, 46, 1584–1600. DOI:10.1093/nar/gkx1239.
  • Weng, Y.; Xiao, H.; Zhang, J.; Liang, X. J.; Huang, Y. RNAi Therapeutic and Its Innovative Biotechnological Evolution. Biotechnol. Adv. 2019, 37, 801–825. DOI:10.1016/j.biotechadv.2019.04.012.
  • Fire, A.; Xu, S. Q.; Montgomery, M. K.; Kostas, S. A.; Driver, S. E.; Mello, C. C. Potent and Specific Genetic Interference by Double-Stranded RNA in Caenorhabditis elegans. Nature 1998, 391, 806–811. DOI:10.1038/35888.
  • Elbashir, S. M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21 ± Nucleotide RNAs Mediate RNA Interference in Cultured Mammalian Cells. Nature 2001, 411, 494–498. DOI:10.1038/35078107.
  • Khvorova, A.; Reynolds, A.; Jayasena, S. D. Functional siRNAs and miRNAs Exhibit Strand Bias. Cell 2003, 115, 209–216. DOI:10.1016/s0092-8674(03)00801-8.
  • Tuschl, T.; Meister, G.; Landthaler, M.; Patkaniowska, A.; Dorsett, Y.; Teng, G. Human Argonaute2 Mediates RNA Cleavage Targeted by miRNAs and siRNAs. Mol. Cell 2004, 15, 185–197. DOI:10.1016/j.molcel.2004.07.007.
  • Matranga, C.; Tomari, Y.; Shin, C.; Bartel, D. P.; Zamore, P. D. Passenger-Strand Cleavage Facilitates Assembly of siRNA into Ago2-Containing RNAi Enzyme Complexes. Cell 2005, 123, 607–620. DOI:10.1016/j.cell.2005.08.044.
  • Dowdy, S. F. Overcoming Cellular Barriers for RNA Therapeutics. Nat. Biotechnol. 2017, 35, 222–229. DOI:10.1038/nbt.3802.
  • Manoharan, M. RNA Interference and Chemically Modified Small Interfering RNAs. Curr. Opin. Chem. Biol. 2004, 8, 570–579. DOI:10.1016/j.cbpa.2004.10.007.
  • Deleavey, G. F.; Damha, M. J. Designing Chemically Modified Oligonucleotides for Targeted Gene Silencing. Chem. Biol. 2012, 19, 937–954. DOI:10.1016/j.chembiol.2012.07.011.
  • Koizumi, K.; Maeda, Y.; Kano, T.; Yoshida, H.; Sakamoto, T.; Yamagishi, K.; Ueno, Y. Synthesis of 4′-C-Aminoalkyl-2′-O-Methyl Modified RNA and Their Biological Properties. Bioorg. Med. Chem. 2018, 26, 3521–3534. DOI:10.1016/j.bmc.2018.05.025.
  • Kano, T.; Katsuragi, Y.; Maeda, Y.; Ueno, Y. Synthesis and Properties of 4′-C-aminoalkyl-2'-fluoro-modified RNA oligomers. Bioorg. Med. Chem. 2018, 26, 4574–4582. DOI:10.1016/j.bmc.2018.08.001.
  • Zhou, P.; Wang, M.; Du, L.; Fisher, G. W.; Waggoner, A.; Ly, D. H. Novel Binding and Efficient Cellular Uptake of Guanidine-Based Peptide Nucleic Acids (GPNA). J. Am. Chem. Soc. 2003, 125, 6878–6879. DOI:10.1021/ja029665m.
  • Shrestha, A. R.; Kotobuki, Y.; Hari, Y.; Obika, S. Guanidine Bridged Nucleic Acid (GuNA): an Effect of a Cationic Bridged Nucleic Acid on DNA Binding Affinity. Chem. Commun. 2014, 50, 575–577. DOI:10.1039/C3CC46017G.
  • Ohmichi, T.; Kuwahara, M.; Sasaki, N.; Hasegawa, M.; Nishikata, T.; Sawai, H.; Sugimoto, N. Nucleic Acid with Guanidinium Modification Exhibits Efficient Cellular Uptake. Angew. Chem. Int. Ed. 2005, 44, 6682–6685. DOI:10.1002/anie.200500904.
  • Gore, K. R.; Nawale, G. N.; Harikrishna, S.; Chittoor, V. G.; Pandey, S. K.; Höbartner, C.; Patankar, S.; Pradeepkumar, P. I. Synthesis, Gene Silencing, and Molecular Modeling Studies of 4′-C-Aminomethyl-2′-O-Methyl Modified Small Interfering RNAs. J. Org. Chem. 2012, 77, 3233–3245. DOI:10.1021/jo202666m.
  • Selvam, C.; Mutisya, D.; Prakash, S.; Ranganna, K.; Thilagavathi, R. Therapeutic Potential of Chemically Modified SiRNA: Recent Trends. Chem. Biol. Drug Des. 2017, 90, 665–678. DOI:10.1111/cbdd.12993.
  • Turner, J. J.; Jones, S. W.; Moschos, S. A.; Lindsay, M. A.; Gait, M. J. MALDI-TOF Mass Spectral Analysis of siRNA Degradation in Serum Confirms an RNAse A-like Activity. Mol. Biosyst. 2007, 3, 43–50. DOI:10.1039/B611612D.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.